ProShare Advisors
ERAS icon

ProShare Advisors’s Erasca ERAS Stock Holding History

ProShare Advisors’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$669K Sell
41,346
-2,870
-6% -$33.9K ﹤0.01% 920
2025
Q4 		$164K Buy
44,216
+4,430
+11% +$12.5K ﹤0.01% 1775
2025
Q3 		$86.7K Sell
39,786
-6,389
-14% -$10.2K ﹤0.01% 1861
2025
Q2 		$58.6K Sell
46,175
-6,366
-12% -$8.52K ﹤0.01% 1973
2025
Q1 		$72K Sell
52,541
-12,614
-19% -$21.6K ﹤0.01% 1897
2024
Q4 		$164K Buy
65,155
+14,921
+30% +$40.9K ﹤0.01% 1947
2024
Q3 		$137K Buy
50,234
+23,385
+87% +$65.9K ﹤0.01% 1825
2024
Q2 		$63.4K Buy
26,849
+1,762
+7% +$3.8K ﹤0.01% 1718
2024
Q1 		$51.7K Buy
25,087
+2,078
+9% +$4.15K ﹤0.01% 1899
2023
Q4 		$49K Buy
23,009
+2,653
+13% +$5.59K ﹤0.01% 1863
2023
Q3 		$40.1K Buy
20,356
+107
+0.5% +$274 ﹤0.01% 1732
2023
Q2 		$55.9K Buy
20,249
+2,193
+12% +$6.25K ﹤0.01% 1761
2023
Q1 		$54.3K Sell
18,056
-410
-2% -$1.49K ﹤0.01% 1664
2022
Q4 		$79.6K Buy
18,466
+1,041
+6% +$7.06K ﹤0.01% 1691
2022
Q3 		$135K Buy
17,425
+650
+4% +$5.24K ﹤0.01% 1490
2022
Q2 		$93K Sell
16,775
-7,758
-32% -$50.8K ﹤0.01% 1623
2022
Q1 		$211K Buy
24,533
+2,858
+13% +$33.1K ﹤0.01% 1854
2021
Q4 		$338K Buy
+21,675
New +$371K ﹤0.01% 1714

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

ProShare Advisors's ERAS Position: Q1 2026 in Review

ProShare Advisors reduced its Erasca (ERAS) stake by 6.5% in Q1 2026, selling an estimated $33.9K and leaving 41,346 shares worth $669K. The position accounts for ﹤0.01% of the portfolio, ranked #920.

ProShare Advisors first reported a position in ERAS in Q4 2021 and has held it in 18 quarters since. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

  • ProShare Advisors held 41,346 shares of Erasca worth $669K as of Q1 2026.
  • ProShare Advisors sold 2,870 Erasca shares in Q1 2026, an estimated $33.9K.
  • Erasca made up ﹤0.01% of ProShare Advisors's portfolio in Q1 2026, its #920 holding.
  • ProShare Advisors first reported a position in Erasca in Q4 2021 and has held it in 18 quarters since.
  • 225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.